Additionally, developing urinary ubiquitinated proteins like FAT10 and URM1 as diagnostic or prognostic biomarkers can improve the clinical management of AKI and facilitate the evaluation of ubiquitin-targeted therapies [58,61]. The gene discussed is URM1; the disease is acute kidney injury.